Phenotypic analysis of retinal leukocyte infiltration during combined cyclosporin A and nasal antigen administration of retinal antigens: delay and inhibition of macrophage and granulocyte infiltration.
Nasal antigen administration successfully suppresses a model of organ-specific autoimmune disease, experimental autoimmune uveoretinitis (EAU), when administered prior to immunisation. We have previously shown that nasal antigen therapy for active disease or in primed, sensitised animals does not reliably or consistently suppress histological disease. However, when nasal antigen administration is combined with cyclosporin A (CsA) therapy, rod outer segment destruction (target organ) is reduced despite the presence of clinical and histological leukocytic infiltration of the eye. In this study, two colour flow cytometric phenotypic analysis of retinal and choroidal leukocytic infiltration of animals treated with either CsA alone, combined therapy with CsA and inhalational tolerance therapy with retinal antigens or sham treated controls was performed. There was no clinical difference between the two treated groups. Flow cytometric phenotypic analysis was performed in all groups at both maximal clinical disease and during resolution of clinical signs. Although the cell number within the infiltrate was reduced in combined treated group, CD4+ IL-2R+ T cells were still present in large numbers, in contrast to the markedly reduced numbers of ED7+ (macrophages/granulocytes) cells infiltrating during height of disease. In the CsA-nasal antigen treated group, when clinical inflammation had subsided, an increase in both macrophages and granulocyte numbers in the chorioretina was observed. The cell numbers were always less than CsA-only treated animals. Despite the late cellular influx of monocytes/macrophages, rod outer segment (ROS) integrity as determined histologically, was maintained. Nasal antigen administration of retinal antigens in CsA-only treated animals (combined therapy group) protects against target organ damage without inhibiting activated T cell traffic to the eye. These results suggest that recruitment of macrophages to the target tissue is central to autoimmune target organ damage, the mechanisms of which are discussed.
Dick
A D
AD
Department of Ophthalmology, Medical School, Aberdeen, Scotland, UK. a.dick@abdn.ac.uk
Kreutzer
B
B
Laliotou
B
B
Forrester
J V
JV
D000281:Administration, Intranasal; D000818:Animals; D000941:Antigens / Q000008:administration & dosage*; D001327:Autoimmune Diseases / Q000139:chemically induced / Q000276:immunology / Q000473:pathology / Q000517:prevention & control; D002417:Cattle; D002634:Chemotaxis, Leukocyte / Q000502:physiology*; D002829:Choroid / Q000276:immunology / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005136:Eye Proteins / Q000008:administration & dosage; D005260:Female; D005434:Flow Cytometry; D006098:Granulocytes / Q000502:physiology*; D016130:Immunophenotyping; D007958:Leukocyte Count; D008264:Macrophages / Q000502:physiology*; D051381:Rats; D011917:Rats, Inbred Lew; D012160:Retina / Q000276:immunology* / Q000473:pathology; D013601:T-Lymphocytes / Q000502:physiology*; D014605:Uveitis / Q000139:chemically induced / Q000276:immunology / Q000473:pathology / Q000517:prevention & control
D000941:Antigens; D005136:Eye Proteins; D016572:Cyclosporine